Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies

Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor, progesterone receptor, or human epidermal growth factor receptor-2, affects nearly 15% of women with breast cancer. To date, the mainstay of treatment remains chemotherapy, with all the associated consequences,...

Descripción completa

Detalles Bibliográficos
Autor principal: Kanwal, Bushra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384383/
https://www.ncbi.nlm.nih.gov/pubmed/34458041
http://dx.doi.org/10.7759/cureus.16636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384383/
https://www.ncbi.nlm.nih.gov/pubmed/34458041
http://dx.doi.org/10.7759/cureus.16636

Ejemplares similares